Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
The Oncologist|June 1, 2013
Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasisElsa Curtit, Virginie Nerich, Laura Mansi, et al.
Rare Tumors|November 9, 2011
Efficacy of trabectedin in metastatic solitary fibrous tumorLoïc Chaigneau, Elsa Kalbacher, Antoine Thiery-Vuillemin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2016
Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian CancerLaura Mansi, Martin Demarchi, Fernando Bazan, et al.
Bulletin Du Cancer|May 30, 2015
[Efficacy, safety and cost of eribulin in patients with metastatic breast cancer]Marie-Justine Paillard, Elsa Curtit, Erion Dobi, et al.
Oncology Reports|February 11, 2017
First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case reportGuillaume Meynard, Laura Mansi, Pierre Lebahar, et al.
Annals of Surgical Oncology|January 7, 2022
Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 PatientsBrice Paquette, Elsa Kalbacher, Frédéric Mercier, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumabQuentin Jacquinot, Nathalie Meneveau, Antoine Falcoz, et al.
Breast Cancer Research : BCR|February 7, 2025
Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruptionMorgane Lopez, Laurie Spehner, Fabrice André, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2016
Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic CellsJeanne Galaine, Guillaume Kellermann, Yves Guillaume, et al.
Cells|December 20, 2018
ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer PhenotypesAurore Claude-Taupin, Leïla Fonderflick, Thierry Gauthier, et al.
Pageof 5